Jonathan D. Adachi

Active 1988–2025

174
Papers
29,387
Citations
97
h-index
168
i10-index

Citations

Citations per year for Jonathan D. Adachi1978: 1 citations1988: 1 citations1990: 2 citations1991: 1 citations1992: 1 citations1993: 4 citations1994: 8 citations1995: 10 citations1996: 25 citations1997: 20 citations1998: 35 citations1999: 48 citations2000: 93 citations2001: 77 citations2002: 92 citations2003: 114 citations2004: 112 citations2005: 206 citations2006: 216 citations2007: 165 citations2008: 234 citations2009: 141 citations2010: 207 citations2011: 155 citations2012: 183 citations2013: 177 citations2014: 194 citations2015: 182 citations2016: 160 citations2017: 194 citations2018: 201 citations2019: 684 citations2020: 820 citations2021: 712 citations2022: 530 citations2023: 402 citations2024: 684 citations2025: 258 citations2026: 13 citations1979–1987: no citations, so these years are not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,004 citing papers, 21.5% of this breakdownUnited Kingdom: 860 citing papers, 9.2% of this breakdownCanada: 708 citing papers, 7.6% of this breakdownChina: 533 citing papers, 5.7% of this breakdownAustralia: 507 citing papers, 5.4% of this breakdownItaly: 390 citing papers, 4.2% of this breakdownGermany: 342 citing papers, 3.7% of this breakdownBelgium: 314 citing papers, 3.4% of this breakdownFrance: 309 citing papers, 3.3% of this breakdownNetherlands: 304 citing papers, 3.2% of this breakdownSwitzerland: 285 citing papers, 3% of this breakdownJapan: 265 citing papers, 2.8% of this breakdown
0%21.5%Other 27%

Fields

  • Medicine81.1%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Health Professions2.2%
  • Engineering1.8%
  • Decision Sciences0.8%
  • Psychology0.7%
  • Other4.2%

Topics

  • Bone health and osteoporosis research19.3%
  • Bone health and treatments8.7%
  • Bone Metabolism and Diseases6.9%
  • Hip and Femur Fractures5.8%
  • Bone and Joint Diseases4.1%
  • Parathyroid Disorders and Treatments2.8%
  • Other52.4%

Coauthors

All papers

Open in search
  1. Romosozumab Treatment in Postmenopausal Women with Osteoporosis

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 1,726

  2. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 1,995

  3. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Serkalem Demissie, Douglas P. Kiel, Mary Bouxsein - The Lancet Diabetes & Endocrinology 2018 cited by 394

  4. Denosumab: mechanism of action and clinical outcomes

    Authors: , , , - International Journal of Clinical Practice 2012 cited by 367

  5. One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

    Authors: , , , , , , , , , - Journal of Bone and Mineral Research 2018 cited by 192

  6. Management of Frailty: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American Medical Directors Association 2019 cited by 188

  7. Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW

    Authors: , , , , , , , , , , , , , , , , , , , , - The American Journal of Medicine 2011 cited by 551

  8. Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease

    Authors: , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2020 cited by 93

  9. The three-year incidence of fracture in chronic kidney disease

    Authors: , , , , , , , , , , - Kidney International 2014 cited by 254

  10. Frailty and Risk of Fractures in Patients With Type 2 Diabetes

    Authors: , , , , , , , , , , , , , - Diabetes Care 2019 cited by 127

  11. Development and validation of a new tool to measure the facilitators, barriers and preferences to exercise in people with osteoporosis

    Authors: , , , - BMC Musculoskeletal Disorders 2017 cited by 439

  12. Treatment failure in osteoporosis

    Authors: , , , , , , , , , , , , , , - Osteoporosis International 2012 cited by 225

  13. Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

    Authors: , , , , , , , , , - The Lancet Diabetes & Endocrinology 2018 cited by 204

  14. Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial

    Authors: , , , , , , , , , - Arthritis & Rheumatology 2019 cited by 139

  15. Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario

    Authors: , , , , , , , , , , - BMC Musculoskeletal Disorders 2021 cited by 107

  16. The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2020 cited by 43

  17. Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2013 cited by 267

  18. Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2021 cited by 56

  19. Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study

    Authors: , , , , , , , , , , , , , , , , , - Canadian Medical Association Journal 2009 cited by 435

  20. An overview of osteoporosis and frailty in the elderly

    Authors: , , , , , - BMC Musculoskeletal Disorders 2017 cited by 217

  21. Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2011 cited by 184

  22. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials

    Authors: , , , , , , - Osteoporosis International 2015 cited by 144

  23. Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality

    Authors: , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2017 cited by 87

  24. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Osteoporosis International 2012 cited by 336